Myriad Genetics to Host Investor Event on October 9, 2024
Myriad Genetics (NASDAQ: MYGN) has announced an Investor Event scheduled for October 9, 2024, at the Westin Grand Central Hotel in New York City. The event, starting at 9:00 am EDT, will last approximately two hours and feature presentations from CEO Paul J. Diaz and other executive leaders.
Topics to be discussed include:
- Long-term growth strategy
- Operational initiatives
- Scientific and clinical advancements in the product pipeline
- Long-term financial goals
In-person attendance requires registration, while a live webcast will be available on Myriad's investor relations website. A replay will be accessible for at least 30 days following the event.
Myriad Genetics (NASDAQ: MYGN) ha annunciato un Evento per Investitori programmato per il 9 ottobre 2024, presso il Westin Grand Central Hotel a New York. L'evento, che inizierà alle 9:00 EDT, durerà circa due ore e presenterà interventi del CEO Paul J. Diaz e di altri leader esecutivi.
Gli argomenti che saranno trattati includono:
- Strategia di crescita a lungo termine
- Iniziative operative
- Progressi scientifici e clinici nella pipeline di prodotti
- Obiettivi finanziari a lungo termine
La partecipazione di persona richiede registrazione, mentre una trasmissione in diretta sarà disponibile sul sito delle relazioni con gli investitori di Myriad. Una registrazione sarà accessibile per almeno 30 giorni dopo l'evento.
Myriad Genetics (NASDAQ: MYGN) ha anunciado un Evento para Inversores programado para el 9 de octubre de 2024, en el Hotel Westin Grand Central de Nueva York. El evento, que comenzará a las 9:00 am EDT, durará aproximadamente dos horas y contará con presentaciones del CEO Paul J. Diaz y otros líderes ejecutivos.
Los temas que se discutirán incluyen:
- Estrategia de crecimiento a largo plazo
- Iniciativas operativas
- Avances científicos y clínicos en la cartera de productos
- Objetivos financieros a largo plazo
La asistencia en persona requiere registro, mientras que una transmisión en vivo estará disponible en el sitio web de relaciones con inversores de Myriad. Una repetición estará accesible durante al menos 30 días después del evento.
Myriad Genetics (NASDAQ: MYGN)은 투자자 행사를 2024년 10월 9일에 뉴욕의 웨스틴 그랜드 센트럴 호텔에서 개최한다고 발표했습니다. 오전 9시 EDT에 시작되는 이 행사는 약 두 시간 동안 진행되며, CEO Paul J. Diaz와 기타 임원들의 발표가 있을 예정입니다.
토론될 주제는 다음과 같습니다:
- 장기 성장 전략
- 운영 이니셔티브
- 제품 파이프라인의 과학적 및 임상 발전
- 장기 재무 목표
현장 참석은 사전 등록이 필요하며, Myriad의 투자자 관계 웹사이트에서 실시간 웹캐스트가 제공됩니다. 행사가 끝난 후 최소 30일간 다시 볼 수 있는 녹화가 제공될 예정입니다.
Myriad Genetics (NASDAQ: MYGN) a annoncé un Événement pour Investisseurs prévu pour le 9 octobre 2024, à l'hôtel Westin Grand Central de New York. L'événement, qui débutera à 9h00 EDT, durera environ deux heures et comprendra des présentations du PDG Paul J. Diaz et d'autres dirigeants exécutifs.
Les sujets à aborder incluent :
- Stratégie de croissance à long terme
- Initiatives opérationnelles
- Avancées scientifiques et cliniques dans le pipeline de produits
- Objectifs financiers à long terme
La participation en personne nécessite une inscription, tandis qu'un webinaire en direct sera disponible sur le site des relations investisseurs de Myriad. Un replay sera accessible pendant au moins 30 jours après l'événement.
Myriad Genetics (NASDAQ: MYGN) hat ein Investoren-Event für den 9. Oktober 2024 im Westin Grand Central Hotel in New York City angekündigt. Die Veranstaltung, die um 9:00 Uhr EDT beginnt, wird etwa zwei Stunden dauern und Präsentationen von CEO Paul J. Diaz und anderen Führungskräften beinhalten.
Die zu besprechenden Themen umfassen:
- Langfristige Wachstumsstrategie
- Betriebliche Initiativen
- Wissenschaftliche und klinische Fortschritte in der Produktpipeline
- Langfristige finanzielle Ziele
Die persönliche Teilnahme erfordert eine Anmeldung, während ein Live-Webcast auf der Investor-Relations-Website von Myriad verfügbar sein wird. Eine Aufzeichnung wird für mindestens 30 Tage nach der Veranstaltung verfügbar sein.
- None.
- None.
SALT LAKE CITY, Sept. 05, 2024 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in genetic testing and precision medicine, will host an Investor Event at the Westin Grand Central Hotel in New York City on October 9, 2024. The in-person event will commence at 9:00 am EDT and last approximately two hours.
Paul J. Diaz, President and CEO, and other members of the Myriad executive leadership team will discuss the company’s long-term growth strategy, operational initiatives, scientific and clinical advancements reflected in its product pipeline, and long-term financial goals.
For those interested in attending the event in person, please register here. For those unable to attend in person, a live webcast of the Investor Event presentation and Q&A will be available on Myriad’s investor relations website at investor.myriad.com. A replay will be posted on Myriad Genetics’ website after the event and will be available for at least 30 days following.
About Myriad Genetics
Myriad Genetics is a leading genetic testing and precision medicine company dedicated to advancing health and well-being for all. Myriad develops and offers genetic tests that help assess the risk of developing disease or disease progression and guide treatment decisions across medical specialties where genetic insights can significantly improve patient care and lower healthcare costs. For more information, visit www.myriad.com.
Investor Contact
Matt Scalo
(801) 584-3532
IR@myriad.com
Media Contact
Glenn Farrell
(385) 318-3718
PR@myriad.com
FAQ
When and where is Myriad Genetics (MYGN) hosting its Investor Event in 2024?
What topics will be covered at Myriad Genetics' (MYGN) October 2024 Investor Event?
How can investors attend or access Myriad Genetics' (MYGN) October 2024 Investor Event?
How long will the replay of Myriad Genetics' (MYGN) October 2024 Investor Event be available?
